Career history of Louis Matis
Former positions of Louis Matis
Companies | Position | Start | End |
---|---|---|---|
PIERIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-08-17 | 2020-01-09 |
Immune Tolerance Institute, Inc.
Immune Tolerance Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of The David H. Murdock Research Institute, Immune Tolerance Institute, Inc. provides integrated, state-of-the-art genomic, cellular, proteomic and bioinformatics technology platforms. The company is based in Menlo Park, CA. Immune Tolerance Institute was acquired by The David H. Murdock Research Institute on June 09, 2011. | Chief Executive Officer | 2006-12-31 | 2009-12-31 |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Chief Executive Officer | 2000-08-31 | 2005-12-31 |
President | 2000-08-31 | 2005-12-31 | |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 1992-12-31 | - |
Training of Louis Matis
Amherst College | Undergraduate Degree |
Perelman School of Medicine | Doctorate Degree |
Statistics
International
United States | 8 |
Operational
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
President | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PIERIS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 4 |
---|---|
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Immune Tolerance Institute, Inc.
Immune Tolerance Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of The David H. Murdock Research Institute, Immune Tolerance Institute, Inc. provides integrated, state-of-the-art genomic, cellular, proteomic and bioinformatics technology platforms. The company is based in Menlo Park, CA. Immune Tolerance Institute was acquired by The David H. Murdock Research Institute on June 09, 2011. | Commercial Services |
- Stock Market
- Insiders
- Louis Matis
- Experience